HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diabetes Insipidus

A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
Networked: 2556 relevant articles (84 outcomes, 108 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hypopituitarism (Sheehan's Syndrome)
2. Hyponatremia
3. Neoplasms (Cancer)
4. Hypothyroidism
5. Diabetes Mellitus

Experts

1. Christ-Crain, Mirjam: 10 articles (05/2022 - 07/2007)
2. Refardt, Julie: 8 articles (01/2022 - 12/2018)
3. Laws, Edward R: 7 articles (06/2022 - 05/2005)
4. Arima, Hiroshi: 7 articles (10/2020 - 05/2009)
5. Rej, Soham: 7 articles (01/2020 - 01/2011)
6. Thompson, Christopher J: 6 articles (06/2017 - 12/2004)
7. Thompson, C J: 6 articles (03/2015 - 10/2002)
8. Oiso, Yutaka: 6 articles (01/2014 - 11/2003)
9. Bichet, Daniel G: 5 articles (01/2022 - 07/2005)
10. Hagiwara, Daisuke: 5 articles (10/2020 - 12/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Diabetes Insipidus:
1. Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
2. Vasopressins (Vasopressin)IBA
3. GlucocorticoidsIBA
4. Hormones (Hormone)IBA
5. Hydrocortisone (Cortisol)FDA LinkGeneric
6. Arginine Vasopressin (Argipressin)IBA
12/01/1995 - "Transient diabetes insipidus in pregnancy--a consequence of enhanced placental clearance of arginine vasopressin."
11/28/2022 - "A working group of representatives from national and international endocrinology and pediatric endocrine societies now proposes changing the name of "diabetes insipidus" to "Arginine Vasopressin Deficiency (AVP-D)" for central etiologies, and "Arginine Vasopressin Resistance (AVP-R)" for nephrogenic etiologies. "
11/17/2022 - "A working group of representatives from national and international endocrinology and endocrine pediatric societies now proposes changing the name of "diabetes insipidus" to "Arginine Vasopressin Deficiency (AVP-D)" for central etiologies, and "Arginine Vasopressin Resistance (AVP-R)" for nephrogenic etiologies This editorial provides both the historical context and the rational for this proposed name change."
11/01/2022 - "A working group of representatives from national and international endocrinology, nephrology and pediatric societies now proposes changing the name of 'diabetes insipidus' to 'arginine vasopressin deficiency (AVP-D)' for central etiologies and 'arginine vasopressin resistance (AVP-R)' for nephrogenic etiologies. "
11/01/2022 - "A working group of representatives from national and international endocrinology, and pediatric endocrine societies now proposes changing the name of 'diabetes insipidus' to 'arginine vasopressin deficiency (AVP-D)' for central etiologies, and 'arginine vasopressin resistance (AVP-R)' for nephrogenic etiologies. "
7. Prednisolone (Predate)FDA LinkGeneric
8. Antidiuretic AgentsIBA
9. ChlorpropamideFDA LinkGeneric
10. ElectrolytesIBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiotherapy
4. Hypophysectomy
5. Conservative Treatment